Oklo Inc. OKLO

Oklo Inc. reported a net loss of $33.1 million for the quarter ended 31 March 2026, while burning $17.9 million in operating cash and ploughing $32.8 million into new plants and equipment. Cash and equivalents stood at $1.59 billion, giving the company a runway that most loss-making firms can only dream of. Earnings per share came in at minus 19 cents on 170.3 million diluted shares, which is the kind of math that makes even the most patient shareholder check the date on the calendar. (source: SEC EDGAR 10-Q, https://www.sec.gov/Archives/edgar/data/1849056/000162828026034095/oklo-20260331.htm)

Oklo’s Aurora line of micro-reactors is engineered to generate between 15 and 75 megawatts from fresh, recycled, or down-blended nuclear fuel, positioning the company at the intersection of next-generation power and next-to-no revenue. Its Abundantia platform promises early commercial output of purified radium and other radioisotopes in 2026, but the 10-Q cheerfully admits no sales have yet materialised. Meanwhile, the Tennessee Valley Authority is exploring a recycling facility and potential power sales from future Oklo powerhouses in the region, which is at least one utility willing to flirt with a start-up that has yet to post a profit. (source: SEC EDGAR 10-Q, https://www.sec.gov/Archives/edgar/data/1849056/000162828026034095/oklo-20260331.htm)

Balance-sheet highlights from the 10-Q include total assets of $2.70 billion, liabilities of $64.9 million, and shareholders’ equity of $2.64 billion. Research and development spend was $27.0 million in the quarter, while capital expenditure on property, plant, and equipment reached $32.8 million. The firm’s cash burn in operating activities was $17.9 million, and the company’s most recent Form 4 filings show routine insider trades rather than any material change in ownership. (source: SEC EDGAR 10-Q, https://www.sec.gov/Archives/edgar/data/1849056/000162828026034095/oklo-20260331.htm)

The company’s $1 billion equity distribution agreement, disclosed on 13 May 2026, allows it to sell common shares through agents at up to a 1.5% commission, but no drawdowns or utilisation have been disclosed in the latest filings. The 10-Q/A filed on 17 June 2026 adjusts some prior-period figures but leaves the headline loss intact; the weight of evidence remains on cash preservation and regulatory disclosure rather than revenue generation. (source: SEC EDGAR 8-K and 10-Q/A, https://www.sec.gov/Archives/edgar/data/1849056/000110465926060385/tm2614461d1_8k.htm and https://www.sec.gov/Archives/edgar/data/1849056/000184905626000037/oklo-20260331.htm)

For context on Oklo’s product pipeline, the Aurora micro-reactor is designed to operate on fresh, recycled, or down-blended nuclear fuel between 15 and 75 megawatts, which is a neat trick if you can pull it off. The International Energy Agency’s long-range outlook, cited in the 10-Q, expects global electricity demand to rise more than 75% by 2050, driven by electrification and cooling demand in developing economies. Oklo’s bet is that decentralised, high-temperature reactors can carve out a niche in that expansion without needing to show revenue today. (source: SEC EDGAR 10-Q and IEA reference, https://www.sec.gov/Archives/edgar/data/1849056/000162828026034095/oklo-20260331.htm)

What remains unproven is whether Aurora or Abundantia can secure the necessary licences, fuel supply, and offtake agreements to monetise the technology. The 10-Q lists $1.59 billion in cash but zero revenue, so the real question is how long the runway lasts before the first commercial kilowatt-hour is delivered. The six Form 4s filed on 15 June 2026 do not change the headline story; they merely remind the market that insiders are active sellers in a company that has not yet turned a profit. (source: SEC EDGAR filings, https://www.sec.gov/edgar/browse/?CIK=1849056)

If you want a single chart to anchor the story, the SEC filings themselves are the primary source of truth for Oklo’s financials and disclosure cadence; no external chart can improve on the raw documents. The tension in the file is straightforward: capital is abundant, revenue is absent, and the next milestone is regulatory approval for a product that has not yet generated a sale. (source: SEC EDGAR companyfacts and submissions JSON, https://data.sec.gov/api/xbrl/companyfacts/CIK0001849056.json and https://data.sec.gov/submissions/CIK0001849056.json)